Glass Michelle, Ashton John C
Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin.
N Z Med J. 2019 May 3;132(1494):49-56.
As New Zealand considers cannabis legal reform, we ask: what exactly is medicinal cannabis, and why does this matter? Cannabis is not a single entity but comes in diverse forms with various active ingredients. This contrasts with the legal and pharmaceutical definitions of medicines, with wide-ranging implications for quality control, prescriber practice and the assessment of clinical evidence. We argue that what is considered a medicine in the legal and pharmaceutical sense should not be changed in an ad hoc way to accommodate cannabis, but that cannabis products should be held to the same standards as other medicines.
在新西兰考虑大麻法律改革之际，我们不禁要问：药用大麻究竟是什么，为何这一点很重要？大麻并非单一物质，而是有多种形式且含有各种活性成分。这与药品的法律和药学定义形成对比，对质量控制、开处方者的做法以及临床证据评估都有广泛影响。我们认为，法律和药学意义上被视为药品的东西不应为了适应大麻而临时改变，大麻产品应与其他药品遵循相同标准。
